Ozempic (semaglutide) is not approved for the treatment of type 1 diabetes. Ozempic is a once-weekly injection that helps lower blood sugar in adults with type 2 diabetes. However, some research ...

In 2017 the U.S. Food and Drug Administration ap­­­proved semaglutide—now widely known as Ozempic. GLP-1 seems to have a secondary function as a satiety signal—a ping to the brain to stop ...